1. Home
  2. BBSI vs NTLA Comparison

BBSI vs NTLA Comparison

Compare BBSI & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$38.14

Market Cap

887.4M

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$10.49

Market Cap

986.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBSI
NTLA
Founded
1965
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
887.4M
986.9M
IPO Year
1993
2016

Fundamental Metrics

Financial Performance
Metric
BBSI
NTLA
Price
$38.14
$10.49
Analyst Decision
Buy
Buy
Analyst Count
2
22
Target Price
$45.50
$19.83
AVG Volume (30 Days)
161.5K
3.6M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
0.85%
N/A
EPS Growth
10.03
N/A
EPS
2.08
N/A
Revenue
$1,223,992,000.00
$57,528,000.00
Revenue This Year
$10.70
$1.96
Revenue Next Year
$7.58
N/A
P/E Ratio
$18.17
N/A
Revenue Growth
9.64
33.52
52 Week Low
$33.01
$5.90
52 Week High
$49.65
$28.25

Technical Indicators

Market Signals
Indicator
BBSI
NTLA
Relative Strength Index (RSI) 62.93 58.76
Support Level $36.73 $8.94
Resistance Level $37.47 $9.62
Average True Range (ATR) 0.81 0.50
MACD 0.23 0.26
Stochastic Oscillator 91.62 75.24

Price Performance

Historical Comparison
BBSI
NTLA

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: